跳至主要内容
临床试验/NCT05488860
NCT05488860Unknown不适用

Piezoelectric Drived Microneedling in Treating Refractory Skin Diseases: A Pilot Study

Xiangya Hospital of Central South University1 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2022年7月30日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
发起方
入组人数
20
试验地点
1
主要终点
Short-term response

研究概览

简要总结

Piezoelectric drived microneedling treats refractory skin disorders using hollow microneedles assisted by ultrasound. Mechanically, the injection of medicine by hollow microneedling could makes the distribution of medicine more evenly. And the addition of ultrasound technique improves the effectiveness of microneedling. Investigators plan to conduct a pilot study to investigate the efficacy of using piezoelectric drived microneedles in treating refractory skin diseases.

详细描述

Piezoelectric drived microneedling treats refractory skin disorders using hollow microneedles assisted by ultrasound. Mechanically, the injection of medicine by hollow microneedling could makes the distribution of medicine more evenly. And the addition of ultrasound technique improves the effectiveness of microneedling. Investigators plan to conduct a pilot study to investigate the efficacy of using piezoelectric drived microneedles in treating refractory skin diseases. Investigators accept participants of hypertrophic scar, keloid and warts. For participants who are not candidates for traditional surgery, investigators will consider to accept carefully.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
16 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age over 16 years
  • Diagnosed by 2 or more professional dermatologists
  • Willing to underwent a new treatment modality
  • Follow up is easy to conduct

排除标准

  • Poor general condition
  • Bleeding tendency
  • Allergy to drug

研究组 & 干预措施

Traditional injection

Active Comparator

Intralesional injection of drug by traditional injection needle. This is the traditional approach for drug delivery recommended by international guidelines for each skin diseases.

干预措施: Triamcinolone acetonide(scar)/5-ALA(others) (Drug)

Piezoelectric drived microneedling

Experimental

Intralesional injection of drug by piezoelectric drived microneedles.

干预措施: Piezoelectric drived microneedling (Procedure)

Piezoelectric drived microneedling

Experimental

Intralesional injection of drug by piezoelectric drived microneedles.

干预措施: 5-ALA (a photosensitizer for photodynamic therapy). (Drug)

结局指标

主要结局

Short-term response

时间窗: 1 week after treatment

This is a qualitative item which should be evaluated by comparing the general images and dermoscopic images pre-treatment and post-treatment carefully.

Long-term response

时间窗: 1 month after treatment

This is a qualitative item which should be evaluated by comparing the general images and dermoscopic images pre-treatment and post-treatment carefully.

次要结局

  • Pain score during treatment(Immediately)
  • POSAS(The Patient and Observer Scar Assessment Scale) score(1 month after treatment)

研究者

发起方
Xiangya Hospital of Central South University
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验